Raleigh, N.C., July 3, 2012 - INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process^® for delivering reliable results, will conduct a conference call to discuss its second quarter 2012 financial results at 11:00 a.m. ET on Monday, August 13, 2012.  The second quarter financial results also will be available on the Company's secure website on Friday, August 10, 2012.

To access the financial results and dial-in information for the conference call, a party must pre-register and certify that it is eligible to do so.  Access to the financial results and conference call will be available only to (1) holders of the Company's 11.5% Senior Notes due 2019, (2) hi-yield securities analysts and broker-dealers and (3) prospective investors that certify that they are qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended.  To receive information on how to pre-register and certify eligibility, parties must send an email to wlumpkin@incresearch.com requesting access to the financial results and conference call information no later than August 10, 2012.  

About INC Research, LLC
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs  in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process^® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.

Contact:
INC Research, LLC
Willis Lumpkin, Treasurer, 919-341-3230